Anlon Healthcare IPO Date, Review, Price, Allotment Details
The initial public offering (IPO) of Anlon Healthcare is scheduled to open on August 26, 2025, and close on August 29, 2025. Anlon Healthcare IPO is a Book Build Issue. The company plans to raise around ₹121.03 crores via IPO, which comprises a fresh issue of ₹121.03 with a face value of ₹10 each.
The pricing range for Anlon Healthcare's IPO is ₹86 to ₹91 per share. The retail quota is 10%, QIB is 75%, and HNI is 15%. Anlon Healthcare IPO to list on BSE, NSE on September 3, 2025. The allotment of the Anlon Healthcare IPO date is September 1, 2025.
The company reported revenue of ₹66.69 crores in 2024 against ₹113.12 crores in 2023. The company reported a profit of ₹9.66 crores in 2024 against a profit of ₹5.82 crores in 2023. As per the financials, the IPO investors should apply for the IPO for the long term.
Anlon Healthcare IPO Details
| IPO Open Date: | August 26, 2025 |
| IPO Close Date: | August 29, 2025 |
| Face Value: | ₹10 Per Equity Share |
| IPO Price Band: | ₹86 to ₹91 Per Share |
| Issue Size: | Approx ₹121.03 Crores |
| Fresh Issue: | Approx ₹121.03 Crores |
| Lot Size: | 164 Shares |
| Issue Type: | Book Build IPO |
| IPO Listing: | BSE & NSE |
| Retail Quota: | Not more than 10% |
| QIB Quota: | Not more than 75% |
| NII Quota: | Not more than 15% |
| DRHP Draft Prospectus: | Click Here |
| RHP Draft Prospectus: | Click Here |
| Anchor Investors List: | Click Here |
Anlon Healthcare IPO Market Lot
The Anlon Healthcare IPO minimum market lot is 164 shares with a ₹14,924 application amount. The retail investors can apply for up to 13 lots with 2,132 shares of ₹1,94,012.
| Application | Lot Size | Shares | Amount |
| Retail Minimum | 1 | 164 | ₹14,924 |
| Retail Maximum | 13 | 2,132 | ₹1,94,012 |
| S-HNI Minimum | 14 | 2,296 | ₹2,08,936 |
| B-HNI Minimum | 68 | 11,152 | ₹10,14,832 |
Anlon Healthcare IPO Dates
The Anlon Healthcare IPO date is August 26 and the close date is August 29. The Anlon Healthcare IPO allotment will be finalized on September 1 and the IPO listing on September 3.
| IPO Open Date: | August 26, 2025 |
| IPO Close Date: | August 29, 2025 |
| Basis of Allotment: | September 1, 2025 |
| Refunds: | September 2, 2025 |
| Credit to Demat Account: | September 2, 2025 |
| IPO Listing Date: | September 3, 2025 |
Promoters of Anlon Healthcare IPO
The promoters of the company are Punit Kumar R. Rasadia, Meet Atul Kumar Vachhani and Mamata Punit Kumar Rasadia.
About Anlon Healthcare IPO
Founded in 2013, Anlon Healthcare Limited is a chemical manufacturing company that specializes in producing active pharmaceutical ingredients (APIs) and pharma intermediates. The company is engaged in the production of active pharmaceutical ingredients and pharmaceutical formulations, high-purity pharmaceutical intermediates, nutraceuticals and the manufacturing of APIs.
The company also provides custom manufacturing for complex chemicals, to a higher purity than expected and with fewer impurities than required, in addition to manufacturing pharma intermediates and APIs to global standards. The company has also obtained Drug Master File (DMF) approvals from ANVISA, NMPA, and PMDA for loxoprofen sodium dihydrate and loxoprofen acid API, with a total of 21 DMFs submitted to global authorities. The company continues to submit for ketoprofen and dexketoprofen trometamol approvals.
Product quality is ensured by rigorous testing, analysis and process improvements based upon interactions with our clients. The company's 34 contributors, including 24 science graduates, and 4 labs combined to do over 30 tests and analyses to provide safe and quality products to our clients and their customers.
Anlon Healthcare IPO Company Financial Report
The company reported revenue of ₹66.69 crores in 2024 against ₹113.12 crores in 2023. The company reported a profit of ₹9.66 crores in 2024 against a profit of ₹5.82 crores in 2023.
Amount in Crores (₹)
| Period Ended | Revenue | Expense | PAT | Assets |
| 2022 | ₹57.54 | ₹57.64 | ₹0.11 | ₹84.97 |
| 2023 | ₹113.12 | ₹106.13 | ₹5.82 | ₹111.55 |
| 2024 | ₹66.69 | ₹56.94 | ₹9.66 | ₹128.00 |
| 2025 | ₹120.46 | ₹93.57 | ₹20.52 | ₹181.30 |
Anlon Healthcare Key Indicators – FY2025
Check Anlon Healthcare IPO valuation details like Earnings Per Share (EPS), Price/Earning Ratio, Return on Net Worth (RoNW), and Net Asset Value (NAV) details.
| KPI | Values |
| ROE: | 25.51% |
| ROCE: | 21.93% |
| EBITDA Margin: | 26.88% |
| PAT Margin: | 17.06% |
| Debt-to-equity ratio: | 0.73 |
| Earning Per Share (EPS): | ₹6.38 (Basic) |
| Price/Earnings Ratio: | N/A |
| Return on Net Worth (RoNW): | 25.51% |
| Net Asset Value (NAV): | ₹20.18 |
Peer Group Comparison
| Company | EPS | PE Ratio | RoNW % | NAV | Income |
| Kronox Lab Sciences Limited | 5.81 | 26.72 | 32.20 | 17.87 | 91.44 Cr. |
| AMI Organics Limited | 11.91 | 197.70 | 6.47 | 183.05 | 701.37 Cr. |
| Supriya Lifesciences Limited | 14.80 | 49.52 | 14.61 | 101.31 | 581.01 Cr. |
Objects of the Issue
- Funding capital expenditure requirements for the Proposed Expansion
- Full or part repayment and/or prepayment of certain outstanding secured borrowings (term loan) availed by the Company
- Funding the working capital requirements of the Company
- General corporate purposes
Anlon Healthcare IPO Registrar
KFin Technologies Limited
Phone: 04067162222, 04079611000
Email: ahl.ipo@kfintech.com
Website: https://kosmic.kfintech.com/ipostatus/
IPO Lead Managers aka Merchant Bankers
- Interactive Financial Services Ltd
Company Address
Anlon Healthcare Ltd.
101/102, Silvercoin Complex,
Opp. Crystal Mall, Kalawad Road,
Rajkot, Gujarat, 360005
Phone: +91 281 2562538
Email: cs@anloncro.com
Website: http://www.anlon.in/